HIGHLIGHTS
- who: BRIEF COMMUNICATION and collaborators from the Institut Eindhoven University have published the paper: An 89Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor, in the Journal: (JOURNAL)
- what: The authors propose an 89Zr-labeled high-density lipoprotein (89Zr-HDL) nanotracer as a means of monitoring response to immunotherapy. The authors explore the use of 89Zr-labeled reconstituted HDL as a macrophage-targeted diagnostic tool that might help clinicians more quickly and accurately assess the response to anti-TAM immunotherapies. This analysis showed a significantly lower radioactivity deposition in tumors from PLX3397-treated mice . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.